InvestorsHub Logo
Followers 43
Posts 2488
Boards Moderated 0
Alias Born 10/19/2015

Re: Doc328 post# 370056

Thursday, 08/11/2022 8:43:26 AM

Thursday, August 11, 2022 8:43:26 AM

Post# of 462247
"The FDA is not out to get Missling or Anavex - at least not any more than the TGA."

Correct. It's easy to lose sight of the fact that there are hundreds if not thousands of other drug candidates, and while Anavex investors believe that Blarcamesine is the most important one and thus ought to be prioritized, that same feeling is shared by other investors about their company's drug pipelines.

The FDA is a government agency. It's not going to move quickly -- there is already so much distrust about government, and the worst thing would be for the FDA to approve a drug that turns out to be ineffective or harmful. I am sure that Dr. Missling is trying to move ahead as quickly as possible, or at least that's what I want to believe because the cynical approach is that he's milking this for more salary, bonuses and stock options. Either way, I'd much rather have a CEO who is diligent and thorough than one who rushes to the finish line only to realize that mistakes were made along the way.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News